Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical features, risk factors, and outcomes of diffuse alveolar hemorrhage in antiphospholipid syndrome: A mixed-method approach combining a multicenter cohort with a systematic literature review.
Figueroa-Parra G, Meade-Aguilar JA, Langenfeld HE, González-Treviño M, Hocaoglu M, Hanson AC, Prokop LJ, Murad MH, Cartin-Ceba R, Specks U, Majithia V, Crowson CS, Duarte-García A. Figueroa-Parra G, et al. Clin Immunol. 2023 Nov;256:109775. doi: 10.1016/j.clim.2023.109775. Epub 2023 Sep 16. Clin Immunol. 2023. PMID: 37722463
Long-Term Opioid Therapy Among Patients With Systemic Lupus Erythematosus in the Community: A Lupus Midwest Network (LUMEN) Study.
Figueroa-Parra G, Jeffery MM, Dabit JY, Chevet B, Valenzuela-Almada MO, Hocaoglu M, Osei-Onomah SA, Kurani S, Vallejo S, Achenbach SJ, Hooten WM, Barbour KE, Crowson CS, Duarte-García A. Figueroa-Parra G, et al. J Rheumatol. 2023 Apr;50(4):504-511. doi: 10.3899/jrheum.220822. Epub 2022 Nov 15. J Rheumatol. 2023. PMID: 36379579 Free PMC article.
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients.
An Z, Figueroa-Parra G, Zhou X, Li Y, Jaquith J, McCarthy-Fruin K, Sletten J, Warrington KJ, Weyand C, Crowson CS, Chumsri S, Knutson KL, Sanchez-Rodriguez A, Thanarajasingam U, Duarte-García A, Zeng H. An Z, et al. Among authors: figueroa parra g. Front Immunol. 2023 Jul 31;14:1224702. doi: 10.3389/fimmu.2023.1224702. eCollection 2023. Front Immunol. 2023. PMID: 37583697 Free PMC article.
Impact of glucocorticoid dose on complete response, serious infections, and mortality during the initial therapy of lupus nephritis: A systematic review and meta-analysis of the control arms of randomized controlled trials.
Figueroa-Parra G, Cuéllar-Gutiérrez MC, González-Treviño M, Sanchez-Rodriguez A, Flores-Gouyonnet J, Meade-Aguilar JA, Prokop LJ, Murad MH, Dall'Era M, Rovin BH, Houssiau F, Tamirou F, Fervenza FC, Crowson CS, Putman MS, Duarte-García A. Figueroa-Parra G, et al. Arthritis Rheumatol. 2024 May 20. doi: 10.1002/art.42920. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 38766897
Clinical presentation and outcomes in patients with antiphospholipid syndrome-associated adrenal hemorrhage. A multicenter cohort study and systematic literature review.
Meade-Aguilar JA, Figueroa-Parra G, Yang JX, Langenfeld HE, González-Treviño M, Dogra P, Bancos I, Moynagh MR, Murad MH, Prokop LJ, Hanson AC, Crowson CS, Duarte-García A. Meade-Aguilar JA, et al. Among authors: figueroa parra g. Clin Immunol. 2024 Mar;260:109906. doi: 10.1016/j.clim.2024.109906. Epub 2024 Jan 19. Clin Immunol. 2024. PMID: 38244823
Calprotectin Impairs Platelet Survival in Patients With Primary Antiphospholipid Syndrome.
Hoy CK, NaveenKumar SK, Navaz SA, Sugur K, Yalavarthi S, Sarosh C, Smith T, Kmetova K, Chong E, Peters NF, Rysenga CE, Norman GL, Figueroa-Parra G, Nelson D, Girard J, Ahmed AZ, Schaefer JK, Gudjonsson JE, Kahlenberg JM, Madison JA, Knight JS, Crowson CS, Duarte-García A, Zuo Y. Hoy CK, et al. Among authors: figueroa parra g. Arthritis Rheumatol. 2024 Jan 16. doi: 10.1002/art.42801. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 38225923
27 results